Huntington National Bank’s Biolase, Inc. BIOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1 Hold
1
﹤0.01% 4093
2025
Q4
$1 Hold
1
﹤0.01% 3998
2025
Q3
$1 Hold
1
﹤0.01% 4027
2025
Q2
$1 Hold
1
﹤0.01% 4036
2025
Q1
$1 Hold
1
﹤0.01% 4047
2024
Q4
$1 Hold
1
﹤0.01% 4043
2024
Q3
$1 Hold
1
﹤0.01% 4035
2024
Q2
$1 Hold
1
﹤0.01% 3984
2024
Q1
$1 Hold
1
﹤0.01% 3850
2023
Q4
$1 Hold
1
﹤0.01% 3748
2023
Q3
$1 Buy
+1
New +$5 ﹤0.01% 3718
2023
Q2
Hold
0
3665
2023
Q1
Hold
0
3536
2022
Q4
Hold
0
3401
2022
Q3
Hold
0
2473
2022
Q2
Hold
0
2484
2022
Q1
Hold
0
2422
2021
Q4
Hold
0
2357
2021
Q3
Hold
0
2098
2021
Q2
Hold
0
1989
2021
Q1
Hold
0
1881
2020
Q4
Hold
0
1855
2020
Q3
Hold
0
1804
2020
Q2
Hold
0
1813
2020
Q1
Hold
0
1904
2019
Q4
Hold
0
1926
2019
Q3
Hold
0
1828
2019
Q2
Hold
0
1863
2019
Q1
Hold
0
1854
2018
Q4
Hold
0
1920
2018
Q3
Hold
0
1924

Huntington National Bank's BIOL Position: Q1 2026 in Review

Huntington National Bank held its Biolase, Inc. (BIOL) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4093.

Huntington National Bank first reported a position in BIOL in Q3 2023 and has held it in 11 quarters since. 1 fund tracked by Wall St. Rank holds BIOL as of Q1 2026.

  • Huntington National Bank held 1 share of Biolase, Inc. worth $1 as of Q1 2026.
  • Huntington National Bank left its Biolase, Inc. share count unchanged in Q1 2026.
  • Biolase, Inc. made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4093 holding.
  • Huntington National Bank first reported a position in Biolase, Inc. in Q3 2023 and has held it in 11 quarters since.
  • 1 fund tracked by Wall St. Rank held Biolase, Inc. as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.